اكتشف أفضل عيادات وتكاليف العلاج سرطان البروستات في ليتوانيا 2026

Prostate cancer treatment in Lithuania primarily includes radical prostatectomy, radiation therapy, and systemic treatments like hormone therapy. Specialist centers in Vilnius and Kaunas utilize laparoscopic and robotic-assisted techniques for localized cases. Advanced protocols follow European standards to ensure high-precision care and rapid recovery.

• Surgical interventions: Surgeons perform radical prostatectomy using laparoscopic or robotic-assisted methods for precision.
• Radiation therapies: Options include external beam radiation and brachytherapy with radioactive source placement.
• Systemic treatments: Advanced cases receive androgen deprivation therapy, chemotherapy, or targeted immunotherapy drugs.
• Early detection: A national program provides PSA testing for men aged 50 to 69.

Bookimed Expert Insight: While many patients focus on surgery, the Medical Diagnostic and Treatment Center in Vilnius emphasizes integrated rehabilitation. This clinic treats over 48,000 patients annually and maintains Joint Commission International (JCI) accreditation. Their approach focuses on rapid functional recovery to help international patients return home sooner after complex urological procedures.

Patient Consensus: Patients emphasize that surgeon experience is vital for avoiding long-term side effects like incontinence. Many recommend getting a second opinion from both a urologist and an oncologist before starting treatment.

Lithuania reports a 94.3% five-year relative survival rate for prostate cancer. This is one of the highest rates in Europe. Early detection programs and increased PSA testing drive these outcomes. Survival rates have climbed from 46.9% since the late 1990s as medical care improved.

• Survival rate range: Outcomes reached 94.3% for patients diagnosed in recent years.
• European ranking: Lithuania ranks second in Europe for net survival after Cyprus.
• Early detection: Nationwide screening for men aged 50–69 began in 2006.
• Urban access: Patients in cities often see higher survival due to faster care.

Bookimed Expert Insight: High survival rates in Lithuania correlate with massive patient volumes at private centers. Medical Diagnostic and Treatment Center alone treats over 48,000 patients annually. This high repetition helps specialists maintain precision in complex robotic and NanoKnife procedures. International patients from the United Kingdom and Norway increasingly choose Vilnius for these outcomes.

Patient Consensus: Patients emphasize that early PSA screening leads to 90% survival for localized cases. Many note that choosing private clinics avoids long waits found in public systems.

Lithuania fully funds prostate cancer screening through the Early Prostate Cancer Detection Programme (EPCDP). The Compulsory Health Insurance Fund covers the cost for insured residents. This includes PSA blood tests, urologist consultations, and biopsies. Screening occurs every 2 to 5 years.

• Target age: Men aged 50 to 69 receive fully covered periodic screenings.
• High-risk groups: Coverage starts at age 45 for those with family history.
• Primary access: A general practitioner must prescribe the initial PSA blood test.
• Specialist care: Referral to a urologist is covered if PSA levels are elevated.

Bookimed Expert Insight: Private clinics like the Medical Diagnostic and Treatment Center in Vilnius handle over 48,000 patients annually. While the government covers basic screening, 10% of patients choose private centers to bypass waitlists. These facilities hold JCI and Temos accreditations, ensuring safety standards identical to Western Europe.

Patient Consensus: Patients note that while the PSA test is free, waitlists for follow-up MRIs can reach 6 months. Many suggest budgeting for private diagnostics to speed up the process if initial results show concerns.

Leading prostate cancer specialists in Lithuania include Dr. Paulius Bosas and Prof. Dr. Balys Dainys. These experts practice at major centers like Kardiolita Hospital and the Medical Diagnostic and Treatment Center. They specialize in laparoscopic surgery and advanced urological oncology for complex cases.

• Dr. Paulius Bosas: Performed over 1,500 laparoscopic and robotic prostate surgeries in Vilnius.
• Prof. Dr. Balys Dainys: Veteran urologist with over 30 years of clinical experience.
• Dr. Marius Kincis: Serves as the President of the Lithuanian Urological Society.
• Dr. Valerijus Ostapenko: Surgical oncologist with over 40 years of cancer treatment experience.

Bookimed Expert Insight: Clinical data shows a high concentration of expertise in Vilnius-based private centers. The Medical Diagnostic and Treatment Center serves over 48,000 patients annually. It holds both JCI and Temos International Healthcare accreditations. This combination of volume and certification is rare in the Baltic region. It suggests a high level of standardized safety for international patients.

Patient Consensus: Patients note that specialized care is centralized in Vilnius and Kaunas hospitals. They recommend having all PSA and biopsy results ready before meeting a specialist.

Lithuania offers high-quality prostate cancer care with a 94.3% 5-year survival rate. This matches Western European standards due to a unique national PSA screening program. Specialized centers in Vilnius provide advanced diagnostics and multidisciplinary treatment at costs significantly lower than in Germany or Austria.

• Early detection: Lithuania maintains the only systematic national PSA screening program in the world.
• Clinical expertise: Major centers like Medical Diagnostic and Treatment Center hold JCI and Temos accreditations.
• Surgical technology: Specialists perform robotic da Vinci prostatectomies, NanoKnife, and targeted hormone therapies.
• High volume: Local surgeons manage high patient loads, fostering expertise that rivals Western European clinics.

Bookimed Expert Insight: A major advantage in Lithuania is the concentration of expertise within a few high-volume private centers. Medical Diagnostic and Treatment Center in Vilnius employs 200 doctors and serves over 48,000 patients annually. While public system wait times can vary, private facilities offer rapid access to PSMA PET scans and robotic surgery. This combination of European Union safety standards and high procedural volume creates a high-value alternative to more expensive clinics in Scandinavia or the United Kingdom.

Patient Consensus: Patients note that robotic surgery in Lithuania costs roughly half as much as in other EU countries. They emphasize that outcomes, particularly regarding recovery speed and maintaining bladder control, are excellent when choosing high-volume surgeons.